ScholarIQanswers from OpenAlex & ORCID
Peter Hau
ResearcherPublications, citations & collaboration network
Peter Hau is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Peter Hau have?
ScholarIQindexed works
Peter Hau has 425 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Peter Hau have?
ScholarIQcitation count
Peter Hau has 29,774 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Peter Hau?
ScholarIQh-index
Peter Hau has an h-index of 57 in OpenAlex.
What is the i10-index of Peter Hau?
ScholarIQi10-index
Peter Hau has an i10-index of 156 in OpenAlex.
What is the ORCID of Peter Hau?
ScholarIQorcid
The ORCID for Peter Hau is on the source record.
What is the OpenAlex record for Peter Hau?
ScholarIQopenalex
The OpenAlex for Peter Hau is on the source record.
What are the most-cited papers on Peter Hau?
ScholarIQmost cited works
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack, Joachim P. Steinbach, Uwe Schlegel, Michael Sabel, Peter Hau, Rolf‐Dieter Kortmann, Dietmar Krex, Oliver Grauer, Roland Goldbrunner, Oliver Schnell, Oliver Bähr, Martin Uhl, Clemens Seidel, Ghazaleh Tabatabai, Thomas E. Kowalski, Florian Ringel, Friederike Schmidt‐Graf, Bogdana Suchorska, Stefanie Brehmer, Astrid Weyerbrock, Miriam Renovanz, Lars Bullinger, Norbert Galldiks, Peter Vajkoczy, Martin Misch, Hartmut Vatter, Moritz Stuplich, Niklas Schäfer, Sied Kebir, Johannes Weller, Christina Schaub, Walter Stummer, Jörg‐Christian Tonn, Matthias Simon, Vera C. Keil, Michael Nelles, Horst Urbach, Martin Coenen, Wolfgang Wick, Michael Weller, Rolf Fimmers, Matthias Schmid, Elke Hattingen, Torsten Pietsch, Christoph Coch, Martin Glas
Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
Ulrich Bogdahn, Peter Hau, Günther Stockhammer, N. K. Venkataramana, Anuspandana Mahapatra, Ashish Suri, Anandh Balasubramaniam, Sujit Nair, V. Oliushine, В. Е. Парфенов, И. Е. Повереннова, Menashe Zaaroor, Piotr Jachimczak, S. Ludwig, S. Schmaus, H. Heinrichs, K.-H. Schlingensiepen, the Trabedersen Glioma Study Group
Inhibition of TGF- <i>β</i> 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies
Peter Hau, Piotr Jachimczak, Reimar Schlingensiepen, Frank Schulmeyer, Tanya Jauch, Andreas Steinbrecher, Alexander Brawanski, Martin Proescholdt, Jürgen Schlaier, Johanna Buchroithner, Josef Pichler, Gabriele Wurm, H. Maximilian Mehdorn, Rainer J. Strege, Gerhard Schuierer, Victoria Villarrubia, Franz A. Fellner, Olav Jansen, Thorsten Straube, Virinder Nohria, Michael Goldbrunner, M. Kunst, S. Schmaus, G. Stauder, Ulrich Bogdahn, Karl‐Hermann Schlingensiepen